BioMed Research International / 2017 / Article / Tab 2 / Clinical Study
A Randomized Trial of Comparing the Efficacy of Two Neurofeedback Protocols for Treatment of Clinical and Cognitive Symptoms of ADHD: Theta Suppression/Beta Enhancement and Theta Suppression/Alpha Enhancement Table 2 Descriptive statistics on cortical activity in two groups.
Scale Group Brain area Pretest Posttest Follow-up Delta Alpha Frontal 0.82 ± 0.57 0.26 ± 0.20 0.29 ± 0.25 Central 0.64 ± 0.38 0.40 ± 0.27 0.45 ± 0.31 Beta Frontal 0.55 ± 0.30 0.33 ± 0.30 0.31 ± 0.26 Central 0.80 ± 0.48 0.50 ± 0.35 0.45 ± 0.31 Theta Alpha Frontal 0.70 ± 0.49 0.48 ± 0.39 0.45 ± 0.44 Central 0.86 ± 0.58 0.62 ± 0.45 0.65 ± 0.49 Beta Frontal 0.55 ± 0.45 0.36 ± 0.26 0.38 ± 0.38 Central 0.52 ± 0.36 0.42 ± 0.29 0.46 ± 0.32 Alpha 1 Alpha Frontal 0.58 ± 0.29 0.53 ± 0.38 0.53 ± 0.40 Central 0.79 ± 0.54 0.61 ± 0.48 0.64 ± 0.40 Beta Frontal 0.52 ± 0.36 0.53 ± 0.45 0.57 ± 0.44 Central 0.51 ± 0.41 0.45 ± 0.30 0.47 ± 0.494 Alpha 2 Alpha Frontal 0.55 ± 0.38 1.12 ± 0.30 0.89 ± 0.44 Central 0.72 ± 0.40 0.80 ± 0.41 0.77 ± 0.47 Beta Frontal 0.30 ± 0.35 0.46 ± 0.39 0.42 ± 0.37 Central 0.60 ± 0.57 0.63 ± 0.51 0.67 ± 0.49 Beta 1 Alpha Frontal 0.77 ± 0.55 0.88 ± 0.57 0.86 ± 0.49 Central 0.82 ± 0.60 1.26 ± 0.46 0.878 ± 0.75 Beta Frontal 0.43 ± 0.31 0.73 ± 0.70 0.69 ± 0.64 Central 0.58 ± 0.56 1.22 ± 0.67 0.84 ± 0.44